Success stories

SARISA Therapeutics 

Dr. Shengmin Sang 

Learn more about Dr. Sang

Patients who require the benefits of aspirin without the accompanying stomach irritation are a step closer to comfort and cures with the signing of an exclusive licensing agreement. Dr. Shengmin Sang, a food scientist with North Carolina Agricultural and Technical State University, licensed his patent for a family of novel aspirin-derived compounds to SARISA Therapeutics, an Invenshure Company out of Minneapolis, Minn. Sang’s patented compounds may be useful in treating or preventing colon cancer, heart disease and other disorders. Through this commercialization effort, more patients may be able to receive the benefits of aspirin without incurring adverse side effects.

In April 2017, the U.S. Preventive Services Task Force added colon cancer to the list of diseases for which aspirin should be prescribed as a preventive treatment. SARISA Therapeutics aims to make Dr. Sang’s discoveries available to all patients who need aspirin’s therapeutic usefulness minus its gastric irritation side effects.


Bio-Adhesive Alliance  

Dr. Elham Fini 

Learn more about Dr. Fini 

Dr. Elham Fini is an associate professor of engineering, and director of N.C. A&T’s sustainable infrastructure materials lab. A J. W. Fulbright Scholar, she has been named to the 2017-2018 class of the Lemelson Invention Ambassadors of the American Association for the Advancement of Science (AAAS). She is also the inventor of patented bio-adhesive technology and co-founder of Bio-Adhesive Alliance.

Bio-Adhesive Alliance produces an eco-friendly, durable, low-cost bio-adhesive from swine manure to help facilitate swine manure management while creating added-value products for the construction industry.Bio-Adhesive Alliance team was recently crowned champion of the ACC Clean Energy Challenge and took first place in the U.S. Department of Energy National Clean Energy Business Plan Competition representing the Southeastern United States.

View the  NSF video showing how pig manure is used in the formulation of asphalt.


Triad Growth Partners 

Dr. Stephanie Luster-Teasley 

Learn more about Dr. Luster-Teasley 

Dr. Stephanie Luster-Teasley is an associate professor and chair of the Department of Civil, Architectural and Environmental Engineering at N.C. A&T. Her research involves chemical oxidation, water and wastewater treatment and remediation. Her patented RemRx™ treatment technology supports the sustainability efforts of Triad Growth Partners in Greensboro, North Carolina.

Triad Growth Partners is developing innovative solutions for the $60 billion remediation market to decrease cost, increase efficacy and restore water and land in a sustainable manner. AxNano (the technology development group of Triad Growth Partners) is designing these advanced solutions as part of Luster-Teasley’s RemRx treatment technologies platform. RemRx brings together advanced technologies to create proprietary and highly tunable products that safely address the needs of global development leaders and industry looking for sustainable solutions.


BioSolar 

Dr. Sung-Jin Cho 

Learn more about Dr. Cho 

Dr. Sung-Jin Cho is an assistant professor and researcher in the Department of Nanoengineering at the Joint School of Nanoscience and Nanoengineering. Cho’s lithium-ion battery research focuses on nanostructured and multifunctional materials with an emphasis on practical applications for energy storage devices. Because of his industry background, Cho believes that truly worthwhile research will be funded generously by the industrial sector because corporate investors are trained to recognize promising technologies which will transform their markets; good research will yield practical applications from which companies will profit. So far, the evidence supports his assertion.

Cho’s research supports BioSolar which is developing a breakthrough technology to double the storage capacity and lower the cost and extend the life of lithium-ion batteries. The company currently co-owns two patent applications for a supercapacitor technology and its super cathode technology. Dr. Cho’s extensive knowledge and leadership in the field of micro-mechanical behavior during the charging and discharging in lithium-ion batteries has been instrumental to the development of BioSolar’s additive material technology which they believe will significantly improve performance of silicon anodes for next generation lithium-ion batteries.


Emb3Ded 

Dr. Salil Desai 

Learn more about Dr. Desai

Micro- and nano scale printing is getting more efficient thanks to a new technology invented by Dr. Salil Desai, a professor in the Department of Industrial and Systems Engineering at N.C. A&T. His invention changes the physical form of droplets exiting a printhead by dramatically reducing their size before their controlled deposition on a flat, curved or flexible substrate. This dramatic level of control maintains the advantages of Emb3Ded’s non-contact printing for use in electronic, biological, and optical manufacturing where contamination is of concern.

Emb3Ded, is an additive manufacturing company with initial focus on biotechnology utilizing 3-D bioprinting. Emb3Ded combines Desai’s patented process and apparatus with multiple additive manufacturing technologies to produce materials and cells that mimic the natural shape of tissues in the human body. Emb3Ded’s products and services are in demand for the biomedical, Regenerative and precision medicine industries.